Article
Azithromycin alters spatial and temporal dynamics of airway microbiota in idiopathic pulmonary fibrosis
2022-09-15
Abstract excerpt
<h4>Background</h4> High bacterial burden in lung microbiota predicts progression of idiopathic pulmonary fibrosis (IPF). Azithromycin is a macrolide antibiotic known to alter the lung microbiota in several chronic pulmonary diseases and observational studies have shown a positive effect of azithromycin on mortality and hospitalization rate in IPF. However, the effect of AZT on lung microbiota in IPF remain unknow...
Topics
Open a Topic to create a Post that cites this publication.
- Bacterial biofilms and quorum sensing
- Clostridium difficile and Clostridium perfringens research
- Cystic Fibrosis Research Advances
- Diet and metabolism studies
- Dysphagia Assessment and Management
- Gut microbiota and health
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Nosocomial Infections in ICU
Identifiers and source
- Literature Corpus work
- 721f582e-53cc-51fb-a392-f40421e908c6
- DOI
- 10.1101/2022.09.14.22279909
